The mammalian elongation complex has remained a mystery – until researchers discovered how it controls its speed.

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

A new study reports that the locations where genes begin are particularly prone to mutations, and these genetic changes can ...

Scientists discovered that the first 100 base pairs of human genes are unusually prone to mutations, especially during the ...

Fluorogenic DNA aptamers produce light only in the correct structural state, enabling programmable molecular logic, ...

Cedars-Sinai scientists have created a new experimental drug called TY1 that helps the body repair damaged DNA and restore ...

Cedars-Sinai scientists have developed an experimental drug that repairs DNA and serves as a prototype for a new class of medications that fix tissue damage caused by heart attack, inflammatory ...

Nobel laureate David Baker’s latest foundation model can design proteins that interact to any biomolecule for broad biotech applications.

In recent years, the complex ecosystem surrounding cancer cells, known as the tumor microenvironment (TME), has become a ...